Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C.

Internal medicine (Tokyo, Japan) - 1 Jan 2015

Kondo Chisa, Atsukawa Masanori, Tsubota Akihito, Shimada Noritomo, Abe Hiroshi, Itokawa Norio, Nakagawa Ai, Fukuda Takeshi, Matsushita Yoko, Nakatsuka Katsuhisa, Kawamoto Chiaki, Iwakiri Katsuhiko, Aizawa Yoshio, Sakamoto Choitsu

Abstract excerpt

OBJECTIVE: Pegylated-interferon/ribavirin (peg-IFN/RBV) therapy with a protease inhibitor is the standard therapy for genotype 1b chronic hepatitis C. Despite improving treatment outcomes, patients with thrombocytopenia are often difficult to treat because interferon commonly exacerbates thrombocytopenia. In this study, partial splenic embolization (PSE) was performed in patients with hypersplenism-induced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Combined Modality Therapy
Share to Interferons

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukins

Share to Oligopeptides

Share to Platelet Count

Share to Polyethylene Glycols

Share to Pyrophosphatases

Share to Thrombocytopenia

Source

Identifiers

PMID: 25743001
DOI: 10.2169/internalmedicine.54.3066

Genes

ITPA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C.PMID 25743001Read ↗

A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia.Semantic proximity Read ↗

Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.Semantic proximity Read ↗

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.Semantic proximity Read ↗

Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C.Semantic proximity Read ↗

Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism.Semantic proximity Read ↗

Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C.Semantic proximity Read ↗

Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.Semantic proximity Read ↗

Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents.Semantic proximity Read ↗

Safety of local thermal ablation in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopeniaSemantic proximity Read ↗

Trans-splenic Sharp Recanalization, Extra-Anatomic Portal Vein Reconstruction, and Intrahepatic Portosystemic Shunt creation for the Treatment of Portal Hypertension in a Patient with Polycythemia Vera and JAK2 Mutation.Semantic proximity Read ↗

Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report.Semantic proximity Read ↗

Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.